Antiviral drug strategies / (Record no. 11141)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05356cam a2200769Ii 4500 |
| 001 - CONTROL NUMBER | |
| control field | ocn729726279 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20171224113647.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cn||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 110609s2011 gw a ob 001 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | DG1 |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | DG1 |
| Modifying agency | YDXCP |
| -- | CDX |
| -- | OCLCQ |
| -- | E7B |
| -- | N$T |
| -- | SCB |
| -- | OCLCQ |
| -- | MHW |
| -- | OTZ |
| -- | IDEBK |
| -- | OCLCQ |
| -- | NLGGC |
| -- | OCLCQ |
| -- | COO |
| -- | OCLCQ |
| -- | TMC |
| -- | D6H |
| 019 ## - | |
| -- | 740225701 |
| -- | 741454003 |
| -- | 778454561 |
| -- | 781264224 |
| -- | 785512762 |
| -- | 816845214 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783527635955 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 3527635955 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783527635979 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 3527635971 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1283140918 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781283140911 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Cancelled/invalid ISBN | 9783527326969 |
| Qualifying information | (hbk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Cancelled/invalid ISBN | 3527326960 |
| Qualifying information | (hbk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Cancelled/invalid ISBN | 9783527635962 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Cancelled/invalid ISBN | 3527635963 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Cancelled/invalid ISBN | 9783527635986 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Cancelled/invalid ISBN | 352763598X |
| 024 8# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 9786613140913 |
| 029 1# - (OCLC) | |
| OCLC library identifier | AU@ |
| System control number | 000047551108 |
| 029 1# - (OCLC) | |
| OCLC library identifier | NZ1 |
| System control number | 14693860 |
| 029 1# - (OCLC) | |
| OCLC library identifier | NZ1 |
| System control number | 15915098 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)729726279 |
| Canceled/invalid control number | (OCoLC)740225701 |
| -- | (OCoLC)741454003 |
| -- | (OCoLC)778454561 |
| -- | (OCoLC)781264224 |
| -- | (OCoLC)785512762 |
| -- | (OCoLC)816845214 |
| 037 ## - SOURCE OF ACQUISITION | |
| Stock number | 10.1002/9783527635955 |
| Source of stock number/acquisition | Wiley InterScience |
| Note | http://www3.interscience.wiley.com |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RS431.A66 |
| Item number | A68 2011 |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
| Classification number | QV268.5 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 071000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.7924 |
| Edition number | 22 |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | MAIN |
| 245 00 - TITLE STATEMENT | |
| Title | Antiviral drug strategies / |
| Statement of responsibility, etc | edited by Erik De Clercq. |
| 264 #1 - | |
| -- | Weinheim : |
| -- | Wiley-VCH ; |
| -- | Chichester : |
| -- | John Wiley [distributor], |
| -- | 2011. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (xx, 406 pages) : |
| Other physical details | illustrations (some color). |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Methods and principles in medicinal chemistry ; |
| Volume number/sequential designation | v. 50 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes bibliographical references and index. |
| 505 00 - FORMATTED CONTENTS NOTE | |
| Title | Outlook of the antiviral drug era, now more than 50 years after description of the first antiviral drug / |
| Statement of responsibility | Erik De Clercq -- |
| Title | Inhibition of HIV entry / |
| Statement of responsibility | José A. Esté -- |
| Title | Targeting integration beyond strand transfer: development of second-generation HIV integrase inhibitors / |
| Statement of responsibility | Arnout R.D. Voet, |
| -- | Marc De Maeyer, |
| -- | Frauke Christ, |
| -- | Zeger Debyser -- |
| Title | From saquinavir to darunavir: the impact of 10 years of medicinal chemistry on a lethal disease / |
| Statement of responsibility | Marie-Pierre de Béthune, |
| -- | Anik Peeters, |
| -- | Piet Wigerinck -- |
| Title | Acyclic and cyclic nucleoside phosphonates / |
| Statement of responsibility | Richard L. Mackman, |
| -- | Tomas Cihlar -- |
| Title | Helicase-primase inhibitors: a new approach to combat herpes simplex virus and varicella zoster virus / |
| Statement of responsibility | Subhajit Biswas, |
| -- | Hugh J. Field -- |
| Title | Cyclophilin inhibitors / |
| Statement of responsibility | Grégoire Vuagniaux, |
| -- | Arnaud Hamel, |
| -- | Rafael Crabbé, |
| -- | Hervé C. Porchet, |
| -- | Jean-Maurice Dumont -- |
| Title | Alkoxyalkyl ester prodrugs of antiviral nucleoside phosphates and phosphonates / |
| Statement of responsibility | James R. Beadle, |
| -- | Karl Y. Hostetler -- |
| Title | Maribavir: a novel benzimidazole ribonucleoside for the prevention and treatment of cytomegalovirus diseases / |
| Statement of responsibility | Karen K. Biron -- |
| Title | Anti-HCMV compounds / |
| Statement of responsibility | Graciela Andrei, |
| -- | Robert Snoeck -- |
| Title | Lethal mutagenesis as an unconventional approach to combat HIV / |
| Statement of responsibility | Pinar Iyidogan, |
| -- | Karen S. Anderson -- |
| Title | Recent progress in the development of HCV protease inhibitors / |
| Statement of responsibility | Nagraj Mani, |
| -- | Bhisetti G. Rao, |
| -- | Tara L. Kieffer, |
| -- | Ann D. Kwong -- |
| Title | Antiviral RNAi: how to silence viruses / |
| Statement of responsibility | Karin J. von Eije, |
| -- | Ben Berkhout -- |
| Title | Neuraminidase inhibitors as anti-influenza agents / |
| Statement of responsibility | Willard Lew, |
| -- | Michael Z. Wang, |
| -- | Xiaowu Chen, |
| -- | James F. Rooney, |
| -- | Choung Kim -- |
| Title | From TIBO to rilpivirine: the chronicle of the discovery of the ideal nonnucleoside reverse transcriptase inhibitor / |
| Statement of responsibility | Erik De Clercq. |
| 588 0# - | |
| -- | Print version record. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses. It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases and primases, as well as their known inhibitors. The final section contains several cases studies of recent successful antiviral drug development. Edited by Erik de. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Antiviral agents |
| General subdivision | Development. |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Antiviral agents |
| General subdivision | Development. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL |
| General subdivision | Pharmacology. |
| Source of heading or term | bisacsh |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Antiviral Agents. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug Discovery. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | De Clercq, Erik. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Print version: |
| Title | Antiviral drug strategies. |
| Place, publisher, and date of publication | Weinheim : Wiley-VCH ; Chichester : John Wiley [distributor], 2011 |
| International Standard Book Number | 9783527326969 |
| Record control number | (OCoLC)664325845 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Methods and principles in medicinal chemistry ; |
| Volume number/sequential designation | v. 50. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://onlinelibrary.wiley.com/book/10.1002/9783527635955 |
| Public note | Wiley Online Library |
| 938 ## - | |
| -- | Coutts Information Services |
| -- | COUT |
| -- | 18076798 |
| 938 ## - | |
| -- | EBL - Ebook Library |
| -- | EBLB |
| -- | EBL693852 |
| 938 ## - | |
| -- | ebrary |
| -- | EBRY |
| -- | ebr10517364 |
| 938 ## - | |
| -- | EBSCOhost |
| -- | EBSC |
| -- | 411148 |
| 938 ## - | |
| -- | Ingram Digital eBook Collection |
| -- | IDEB |
| -- | 314091 |
| 938 ## - | |
| -- | YBP Library Services |
| -- | YANK |
| -- | 7279829 |
| 938 ## - | |
| -- | YBP Library Services |
| -- | YANK |
| -- | 5559632 |
| 938 ## - | |
| -- | YBP Library Services |
| -- | YANK |
| -- | 12679352 |
| 994 ## - | |
| -- | 92 |
| -- | DG1 |
No items available.